Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

• Status: Terminated
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assistance Publique - Hôpitaux de Paris
• Treatments: Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• Women>18 years,

• during first stage of normal labor,

• at 36 to 42 weeks,

• with epidural analgesia and informed signed consent

Exclusion Criteria:

• Cesarean section delivery,

• clotting disorders,

• prostaglandin allergy,

• absent consent.